Company / Net Debt per Share
LEXICON PHARMACEUTICALS, INC. Net Debt per Share History
FY2013-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Debt per Share
$0.04
FY2025
5-year range
$0.04 / $1.90
FY2021-FY2025
Trend
-79.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Net Debt per Share has declined for 4 consecutive years, from $1.90 in FY2018 to $0.04 in FY2025.
Based on SEC 10-K filings.
0.04 in FY2025 with a 10-year CAGR of -26.5%.
Improved from $0.53 to $0.04 over the past 2 years.
Net Debt per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -26.5%
Key checks
Key Insights
- LEXICON PHARMACEUTICALS, INC.'s net debt per share has declined for 4 consecutive years.
- In FY2025, net debt per share decreased 79.5% year-over-year.
- Peak net debt per share was recorded in FY2018.
- Lowest net debt per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -1.98 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.04 | -79.5% |
| FY2024 | $0.20 | -61.6% |
| FY2023 | $0.53 | -67.1% |
| FY2019 | $1.61 | -15.3% |
| FY2018 | $1.90 | +588.3% |
| FY2017 | $0.28 | +140.4% |
| FY2016 | -$0.68 | -175.5% |
| FY2015 | $0.90 | +675.9% |
| FY2014 | $0.12 | +123.9% |
| FY2013 | -$0.49 | -482.9% |
As of FY2025 · SEC 10-K Annual Filings · Updated Jun 24, 2026